Treatment Duration of Febrile Urinary Tract Infections
| Autor: | Jaap T. van Dissel, Cees van Nieuwkoop, Willize E. van der Starre |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Treatment duration Urinary system Antibiotics Complicated urinary tract infection Prostatitis Urinary Tract Infections (Jack D. Sobel Section Editor) law.invention Randomized controlled trial law Internal medicine medicine Intensive care medicine Acute pyelonephritis business.industry Febrile urinary tract infections medicine.disease Fluoroquinolone resistance Regimen Infectious Diseases Bacteremia business Fluoroquinolones |
| Zdroj: | Current Infectious Disease Reports |
| ISSN: | 1534-3146 1523-3847 |
| Popis: | Although febrile urinary tract infections (UTIs) are relatively common in adults, data on optimal treatment duration are limited. Randomized controlled trials specifically addressing the elderly and patients with comorbidities have not been performed. This review highlights current available evidence. Premenopausal, non-pregnant women without comorbidities can be treated with a 5–7 day regimen of fluoroquinolones in countries with low levels of fluoroquinolone resistance, or, if proven susceptible, with 14 days of trimethoprim-sulfamethoxazole. Oral β-lactams are less effective compared with fluoroquinolones and trimethoprim-sulfamethoxazole. In men with mild to moderate febrile UTI, a 2-week regimen of an oral fluoroquinolone is likely sufficient. Although data are limited, this possibly holds even in the elderly patients with comorbidities or bacteremia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink